Literature DB >> 1715690

Nerve growth factor binds to the 140 kd trk proto-oncogene product and stimulates its association with the src homology domain of phospholipase C gamma 1.

M Ohmichi1, S J Decker, L Pang, A R Saltiel.   

Abstract

The cellular actions of nerve growth factor (NGF) involve regulation of protein phosphorylation. In PC-12 pheochromocytoma cells, exposure of [125I]NGF followed by crosslinking indicates that the ligand binds to two discreet receptors, the previously described 75 kd protein, as well as the trk proto-oncogene product pp140c-trk. Competition experiments reveal that of the two, pp 140c-trk binds to NGF with higher affinity. Following exposure to NGF, pp140c-trk undergoes a rapid autophosphorylation on tyrosine residues, and concomitantly phosphorylates and associates with phospholipase C gamma 1 (PLC gamma 1), through interaction with its src homology domains. The binding of NGF to pp140c-trk with high affinity, the NGF-dependent homology domains. The binding of NGF to pp140c-trk with high affinity, the NGF-dependent activation of its tyrosine kinase activity and the specific association with the effector molecule, PLC gamma 1, suggests that this is the biologically relevant signaling receptor for NGF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715690     DOI: 10.1016/0006-291x(91)91357-i

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors.

Authors:  S Cockcroft; G M Thomas
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 2.  Slitrks as emerging candidate genes involved in neuropsychiatric disorders.

Authors:  Catia C Proenca; Kate P Gao; Sergey V Shmelkov; Shahin Rafii; Francis S Lee
Journal:  Trends Neurosci       Date:  2011-03       Impact factor: 13.837

3.  Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.

Authors:  R J Crowder; R S Freeman
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

4.  Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor.

Authors:  M H Cortazzo; E S Kassis; K A Sproul; N F Schor
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

5.  HC fragment (C-terminal portion of the heavy chain) of tetanus toxin activates protein kinase C isoforms and phosphoproteins involved in signal transduction.

Authors:  C Gil; I Chaib-Oukadour; J Blasi; J Aguilera
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

6.  Direct analysis of the binding of Src-homology 2 domains of phospholipase C to the activated epidermal growth factor receptor.

Authors:  G Zhu; S J Decker; A R Saltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase.

Authors:  K L Milarski; D F Lazar; R J Wiese; A R Saltiel
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

8.  Nerve growth factor activates calcium-insensitive protein kinase C-epsilon in PC-12 rat pheochromocytoma cells.

Authors:  M Ohmichi; G Zhu; A R Saltiel
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

9.  From sets to graphs: towards a realistic enrichment analysis of transcriptomic systems.

Authors:  Ludwig Geistlinger; Gergely Csaba; Robert Küffner; Nicola Mulder; Ralf Zimmer
Journal:  Bioinformatics       Date:  2011-07-01       Impact factor: 6.937

10.  Tyrosine 785 is a major determinant of Trk--substrate interaction.

Authors:  A Obermeier; H Halfter; K H Wiesmüller; G Jung; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.